Navigation Links
NDC Completes Acquisition of Phase One Medical(R) Anchoring Technology
Date:3/2/2009

FREMONT, Calif., March 2 /PRNewswire/ -- Nitinol Devices & Components, Inc. (NDC) announced today that they recently acquired a novel medical device anchoring technology from Phase One Medical, LLC, brokered by Hatch Medical, LLC. This anchoring technology integrates the superelastic material properties of nitinol with proprietary anchoring design elements to provide secure fixation and removability for minimally invasive medical devices. The technology is anticipated to provide a platform for the production of a spectrum of innovative medical device therapies to the cardiovascular surgery and interventional radiology community.

Traditional anchoring technologies include, for example, barbs or hooks in vena cava filters, radial outward forces in endovascular stents, and pinching in atrial septal defect closure devices. Each of these technologies requires significant interaction with the surrounding anatomy such that the native biomechanics are disturbed, at times resulting in negative clinical outcomes. Many of these implantable devices are needed only for a short duration to assist in the natural healing process, after which time the device is no longer necessary and the body could benefit from removal of the device if the biological risks associated with removal are minimal.

The anchoring technology acquired from Phase One Medical offers several key advantages over those conventional technologies while retaining the same small dimensions required to deliver devices using minimally invasive techniques. First, this technology decouples device delivery and anchoring into two separate steps, allowing physicians the opportunity to fully unsheath devices in vivo, position them as necessary, and anchor the devices only after precise placement has been achieved. Second, the anchors may be retracted during the initial implantation procedure even after attachment to the anatomy, thereby providing physicians with multiple opportunities for optimal placement. Next, unlike many medical implants that require several days or weeks for biological tissue ingrowth to assist in the anchoring, the current anchoring technology affixes the device in position without the need of tissue ingrowth, thereby greatly reducing the possibility of migration prior to endothelialization. Finally, when clinically warranted, the anchors are easily removable leaving behind only immediately self-sealing holes smaller than those created by most sutures.

Phase One Medical is a privately held medical device research and development company. The company is focused on development of new and innovative technology supported by generation of strong IP positions. For more information about Phase One Medical, its product licensing history and other active projects visit the company's website at http://www.phaseonemedical.com

NDC is a privately held supplier of nitinol raw materials (wire, sheet, tube, strip and bar), manufacturer of customized components, and offers a wide range of engineering services (mechanical, fatigue and corrosion testing, process development, finite element computer modeling, surface characterization, metallurgical evaluation, and failure analysis) in support of the medical device industry. Their acquisition of the anchoring technology represents an additional medical device incubator endeavor intended to develop innovative implantable therapeutic solutions to challenging clinical problems. This release and additional news about NDC can be obtained by visiting the company's website at: http://www.nitinol.com/


'/>"/>
SOURCE Nitinol Devices & Components, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... The American ... productivity, stability, even security. Most importantly, employees are the single most important asset ... American workers so unhappy? , Just under half of American workers are emotionally ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Conditions were ideal ... Cove Island Park on Sunday, with sunny skies, a light breeze and temperatures in ... $33,000. , The 5k Run and Walk and 1-mile walk were held ...
(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment ... been invited to be a featured speaker at the Texas Society of the American ... 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Dr. Robert ... dental treatments to improve smiles. Cosmetic dentistry is a fast-growing field as more patients ... offer allows patients to learn more about the options currently available to them and ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Click here for supplemental information regarding ... the nation,s largest independent specialty pharmacy, announced today ... acquire Valley Campus Pharmacy, Inc., doing business as ... pharmacy that provides individualized patient care, based in ... 2015, TNH generated approximately $400 million in revenue. ...
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... , April 28, 2016 ... insights on healthcare, announced today that it has been ... Cool Vendor in Life Sciences, 2016, ... 2016.  The report focuses on life-science- oriented analytics, algorithms ... from patients and doctors, confirm medication ingestion, and analyze ...
Breaking Medicine Technology: